serena williams glp-1 medication faces backlash after Super Bowl Ad promoting weight-loss drug Serena Williams broke her silence

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management as Zepbound

But the shape, the accumulation pattern, the relative timing of peaks and troughs, these remain accurate enough to guide practical decisions

Important upfront: in the Western pharmaceutical world BPC-157 never passed Phase 3 trials (= the large clinical trials required before drug approval)

She is dedicated, motivated and passionate about developing relationships with her patients that foster safe and high quality patient centered care

, , ,

GIP may enhance the benefits of the GLP-1 medication